E. B. Edwards

TL;DR: A number of guidelines were established for creating an index of disease severity to estimate survival in patients with chronic liver disease and it was determined that such a disease severity index should rely on a few, readily available, objective variables that would be generally applicable to a heterogeneous group of patients with end-stage liver disease.

TL;DR: The year saw the largest number of liver transplants to date, leading to reductions in median waiting time, in waitlist mortality for all model for end‐stage liver disease categories, and in the number of candidates on the waiting list at the end of the year.

TL;DR: A continuous score incorporating MELD, AFP and tumor size may help to prioritize HCC patients to better equate dropout rates with non‐HCC patients and equalize access.

TL;DR: It is concluded that factors associated with the risk of removal for HCC are different from NM candidates, although MELD score at listing remains the most predictive for both groups, and Liver transplant candidates with HCC may be prioritized using a risk score analogous to the MELD Score.

TL;DR: Intestine and intestine‐liver transplant remains important in the treatment of intestinal failure, despite decreased morbidity associated with parenteral nutrition, and pretransplant mortality rate decreased dramatically over time for all age groups.